Haematological Disease

Haematological Disease

Zobrazit další vydání (1)

Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the...

Podrobná bibliografie
Hlavní autoři:	Estcourt, L, Stanworth, S, Murphy, M
Médium:	Book section
Vydáno:	John Wiley and Sons 2013

Podobné jednotky

Haematological Disease
Autor: Murphy, M, a další
Vydáno: (2009)

Platelet transfusions for patients with haematological malignancies: who needs them?
Autor: Estcourt, L, a další
Vydáno: (2011)

Intracranial haemorrhage in thrombocytopenic haematology patients—a nested case–control study: the InCiTe study protocol
Autor: Estcourt, L, a další
Vydáno: (2014)

Intracranial hemorrhage in patients with haematological malignancy, a nested case-control study
Autor: Estcourt, L, a další
Vydáno: (2017)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Autor: Estcourt, L, a další
Vydáno: (2016)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
Autor: Wardrop, D, a další
Vydáno: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
Autor: Wardrop, D, a další
Vydáno: (2013)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
Autor: Desborough, M, a další
Vydáno: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Autor: Estcourt, L, a další
Vydáno: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
Autor: Estcourt, L, a další
Vydáno: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Autor: Estcourt, L, a další
Vydáno: (2015)

Prophylactic platelet transfusions
Autor: Estcourt, L, a další
Vydáno: (2010)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Autor: Estcourt, L, a další
Vydáno: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
Autor: Estcourt, L, a další
Vydáno: (2015)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
Autor: Estcourt, L, a další
Vydáno: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
Autor: Estcourt, L, a další
Vydáno: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
Autor: Estcourt, L, a další
Vydáno: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
Autor: Estcourt, L, a další
Vydáno: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study
Autor: Estcourt, L, a další
Vydáno: (2014)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
Autor: Stanworth, S, a další
Vydáno: (2006)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
Autor: Estcourt, L, a další
Vydáno: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
Autor: Stanworth, S, a další
Vydáno: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
Autor: Stanworth, S, a další
Vydáno: (2014)

2016 National audit of red cell use in adult haematology patients
Autor: Karakantza, M, a další
Vydáno: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
Autor: Crighton, GL, a další
Vydáno: (2015)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
Autor: Butler, C, a další
Vydáno: (2011)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
Autor: Crighton, GL, a další
Vydáno: (2021)

Pathogen-reduced platelets for the prevention of bleeding (Review)
Autor: Estcourt, L, a další
Vydáno: (2017)

Is sepsis a risk factor for bleeding in adults with hematologic malignancies?
Autor: Estcourt, L, a další
Vydáno: (2017)

Pathogen-reduced platelets for the prevention of bleeding (Review)
Autor: Butler, C, a další
Vydáno: (2013)

Pathogen-reduced platelets for the prevention of bleeding.
Autor: Butler, C, a další
Vydáno: (2013)

Transfusion practice and safety: current status and possibilities for improvement.
Autor: Murphy, M, a další
Vydáno: (2011)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews 2. Analysis of the combined results from the included studies.
Autor: Hyde, C, a další
Vydáno: (2008)

Evidence for indications of fresh frozen plasma.
Autor: Stanworth, S, a další
Vydáno: (2007)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews.
Autor: Hyde, C, a další
Vydáno: (2008)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
Autor: Campbell, H, a další
Vydáno: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
Autor: Campbell, H, a další
Vydáno: (2014)

Platelet transfusions in haematology patients: are we using them appropriately?
Autor: Estcourt, L, a další
Vydáno: (2012)

Alternatives to allogeneic platelet transfusion
Autor: Desborough, M, a další
Vydáno: (2016)

Putting clinical trials into context.
Autor: Hyde, C, a další
Vydáno: (2005)